Surajeet Das Gupta &Amp; Sohini Das

Stories by Surajeet Das Gupta &Amp; Sohini Das

Airtel takes a leaf out of Jio as telecom battle intensifies

Airtel takes a leaf out of Jio as telecom battle intensifies

Rediff.com   13 Sep 2021

When, recently, Bharti Airtel announced a Rs 21,000 crore rights issue, analysts pointed out that its structure was similar to that of Reliance's issue in June 2020. One similarity is that shareholders in both companies have to pay only 25 per cent of the money on application. The rest is to be paid in two tranches. In Bharti Airtel's case, it is within 36 months; in Reliance Jio's, it is within 17 months.

'Made in India' iPhones make Apple's 70% India sales

'Made in India' iPhones make Apple's 70% India sales

Rediff.com   6 Sep 2021

In a major push towards 'Make in India', Apple Inc is manufacturing 70 per cent of the mobile phones, in value terms, that it sells in the domestic market, in India, according to sources aware of the development. This is a sharp rise from the figure of 30 per cent just two years ago and marks a major shift in Apple's strategy following the government's Production Linked Incentive (PLI) scheme that kicked off in FY'21. One of Apple's three vendors here, Foxconn, is currently manufacturing the best-selling model, the Apple 11, along with the Apple 10 and the Apple 12. Another contract manufacturer, Wistron, makes the Apple SE 2020. (The third, Pegatron, has yet to start production). The only models that are imported (they have limited volumes but high value) are the Apple 12 Pro and Pro Max.

China's tech crackdown may be good news for Indian start-ups

China's tech crackdown may be good news for Indian start-ups

Rediff.com   2 Sep 2021

The Chinese government is imposing severe restrictions on their tech companies - whether it is on data security, marketing practices or floating an IPO. Should this be music to the ears of Indian start-ups and home-grown private equity (PE) funds? Ask Indian start-ups and the answer is a resounding "yes".

Focus on hospitals as India braces for Covid third wave

Focus on hospitals as India braces for Covid third wave

Rediff.com   1 Sep 2021

The health system is trying to ensure that it isn't caught by surprise -- the way it was last time. So, hectic preparations are on.

Pharma majors shift focus to inhalants, nasal spray for Covid

Pharma majors shift focus to inhalants, nasal spray for Covid

Rediff.com   30 Aug 2021

While Lupin is working on a Remdesivir powder for inhalation, Glenmark has tied up with a Canadian Biotech firm for nitric oxide nasal spray that reduces Sars-CoV-2 viral load and thus transmission.

Gennova's mRNA Covid vaccine gets nod for Phase 2-3 trials

Gennova's mRNA Covid vaccine gets nod for Phase 2-3 trials

Rediff.com   25 Aug 2021

If things go according to plan, the vaccine would be available in the market by the end of this year.

What if Vodafone Idea shuts shop?

What if Vodafone Idea shuts shop?

Rediff.com   21 Aug 2021

Reliance Jio and Bharti Airtel have enough capacity to absorb over 113.9 million Vodafone Idea subscribers who are on 4G if Vodafone Idea has to shut operations.

Novovax Covid vaccine likely to get nod in India ahead of US

Novovax Covid vaccine likely to get nod in India ahead of US

Rediff.com   18 Aug 2021

Adar Poonawalla said he was hopeful that Covovax, the Novavax vaccine made by SII, will be launched around October this year for adults and for children by the first quarter of next year, depending on DCGI approvals.

Govt stands to lose whether it saves debt-laden Vodafone Idea or not

Govt stands to lose whether it saves debt-laden Vodafone Idea or not

Rediff.com   12 Aug 2021

The government will have to make substantial payments, as well as forego revenues in FY'23, if it wants to work on the survival of Vodafone Idea because it will have to extend the same incentives to the entire telecom sector. According to estimates, the industry has to spend around Rs 21,000-Rs 25,000 crore for spectrum which it bought on a deferred payment basis. Vodafone Idea has asked for a moratorium for another year (FY23). If granted, the government will have foregone the instalment payout for a third year in a row as it has already provided a moratorium for two years, giving telcos Rs 42,000 crore worth of relief.

Ed-tech giant Byju's eyes $1 billion revenue in US by 2024

Ed-tech giant Byju's eyes $1 billion revenue in US by 2024

Rediff.com   11 Aug 2021

Byju's has quietly moved into other global markets such as the UK, Australia and New Zealand. It recently launched operations in Latin America.

Despite nod foreign Covid vaccines likely to be delayed over indemnity clause

Despite nod foreign Covid vaccines likely to be delayed over indemnity clause

Rediff.com   11 Aug 2021

India is not keen to 'bow down' to demands related to indemnity against legal liabilities in case any vaccine recipient develops severe adverse reactions post inoculation.

How Tatas plan to grab the $100 billion-plus global 5G market

How Tatas plan to grab the $100 billion-plus global 5G market

Rediff.com   10 Aug 2021

The Tata group's tryst with mobile services, with either CDMA or GSM technology, did not really fly, forcing it to close operations and write off losses. Now the group is back in the big game, this time straddling the telecom equipment, network and technology space in India as well as the global market. To this end, it is leveraging the opportunities that flow from 5G technology through open radio access network, or O-RAN. Recently, the Tata Sons' subsidiary Panatone Finvest acquired 43.3 per cent in Bengaluru-based telecom equipment manufacturer Tejas Network for Rs 1,850 crore and announced it would buy another 26 per cent of the voting capital through an open offer.

Meeting 1.35 bn vax dose target in Aug-Dec a long haul

Meeting 1.35 bn vax dose target in Aug-Dec a long haul

Rediff.com   6 Aug 2021

While Covishield supplies would meet the target of 500 mn doses between August and December, it looks like Covaxin would miss the target of 400 mn unless the partner sites of Bharat Biotech ramp up very rapidly, reports Sohini Das.

Private Equity Funds toy with Exit via SPACs

Private Equity Funds toy with Exit via SPACs

Rediff.com   3 Aug 2021

Discussion has started between blank check companies in the US and Indian PEs on possible deals in certain key sectors.

AstraZeneca finds small clot risk after 1st Covid shot

AstraZeneca finds small clot risk after 1st Covid shot

Rediff.com   29 Jul 2021

But no extra risk after second dose, shows study led and funded by drug maker, reports Sohini Das.

Russia reaches out to Kerala for Sputnik V plant

Russia reaches out to Kerala for Sputnik V plant

Rediff.com   29 Jul 2021

The government may look at areas around Thonnakkal, in Thiruvananthapuram district, for the facility. If successful, this would be one of the few sites of Sputnik V owned by Russian firms outside that country. Shine Jacob and Sohini Das report.

3rd wave: Govt creating 30-day stock of key Covid medicines

3rd wave: Govt creating 30-day stock of key Covid medicines

Rediff.com   26 Jul 2021

'The Centre is planning to procure five million vials of Remdesivir ahead of the third wave. What's better is that this time, the government is paying us in advance,' said a senior executive of a Mumbai-based pharma player which makes Remdesivir. Sohini Das reports.

A peek into Mukesh Ambani's big retail push

A peek into Mukesh Ambani's big retail push

Rediff.com   26 Jul 2021

Mukesh Ambani's Reliance group has struck acquisition deals worth $4.2 billion with a dozen companies in just two years to expand its retail business. The latest purchase was of a majority stake in Justdial for Rs 3,497 crore. Elaborating on his acquisition strategy a few weeks ago during the AGM, Ambani stated that one of the key planks would be to acquire businesses that enhanced Reliance's offerings and experiences to customers and that they would be both physical and digital.

Zydus Cadila to begin vaccine trials for kids above 5 yrs soon

Zydus Cadila to begin vaccine trials for kids above 5 yrs soon

Rediff.com   19 Jul 2021

So far, no other vaccine has been approved globally for children below 12 years. Sohini Das reports.

Why Voda Idea's options for survival are narrowing

Why Voda Idea's options for survival are narrowing

Rediff.com   14 Jul 2021

Vodafone Idea Ltd (VIL) CEO Ravinder Takkar did some plain speaking. In an analyst call after its quarterly results recently, Takkar said that the main stumbling block to raising fresh capital from investors is "pricing" - telecom tariffs, in other words. Nine months ago, the telecom company's board had cleared a proposal for raising Rs 25,000 crore from investors, after the promoters made it clear that they were not ready to pump in more money. But potential investors are concerned that without clarity on tariff hikes (there have been none for more than 18 months) they might just lose their money. The lack of visibility on raising tariffs has also impelled VIL to request the Department of Telecom (DoT) for a fresh reprieve by extending the two-year moratorium on paying its spectrum instalment of Rs 8,200 crore for another year till FY23.